The leadership of BGG, an astaxanthin production and technology company, anticipates nutraceutical ingredients from algae will rapidly develop into a large and thriving segment of the supplement industry.  With that in mind, the company has decided to spin off its astaxanthin farm into a subsidiary in which BGG will remain the major shareholder that will have its sole focus on the production and marketing of efficacious ingredients from natural algae sources. The company will be named “Algae Life Sciences, Inc.” but will go to market simply as “AlgaeLife.”  The company will have offices in the U.S., Switzerland, Japan and China.  While it will be a separate corporate entity, AlgaeLife will continue to utilize BGG’s quality facilities and scientists as well as its worldwide Sales Team. 
 
“Our goal is to provide the absolute highest quality algae-based ingredients at favorable pricing,” said industry veteran Joe Huff, CEO of AlgaeLife’s U.S.-based operation. “We plan to introduce new products on a consistent basis in the coming years, but for now we’re extremely excited about the prospects for our flagship product astaxanthin. And we’re thrilled to have the worldwide reputation for quality ingredients that BGG has gained over the last twenty years backing us.”  
 
In addition to Mr. Huff who has served in a variety of roles in the supplement industry including sales, purchasing and quality, AlgaeLife has also employed Bob Capelli as its executive vice president of global marketing. Mr. Capelli has spent the last 14 years researching, publicizing and marketing astaxanthin. He has been published extensively including the world’s first book on astaxanthin, peer-reviewed papers, magazine articles as well as appearing on countless radio and TV shows around the world as an expert on astaxanthin.